乳腺浸润性导管癌中Paxillin和Caspase-3蛋白的表达及临床意义

仲广生 李孟圈 苏静

仲广生, 李孟圈, 苏静. 乳腺浸润性导管癌中Paxillin和Caspase-3蛋白的表达及临床意义[J]. 中国肿瘤临床, 2012, 39(1): 22-25. doi: 10.3969/j.issn.1000-8179.2012.01.006
引用本文: 仲广生, 李孟圈, 苏静. 乳腺浸润性导管癌中Paxillin和Caspase-3蛋白的表达及临床意义[J]. 中国肿瘤临床, 2012, 39(1): 22-25. doi: 10.3969/j.issn.1000-8179.2012.01.006
Guangsheng ZHONG, Mengquan LI, Jing SU. Expression and Clinical Significance of Paxillin and Caspase-3 in Breast Invasive Ductal Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(1): 22-25. doi: 10.3969/j.issn.1000-8179.2012.01.006
Citation: Guangsheng ZHONG, Mengquan LI, Jing SU. Expression and Clinical Significance of Paxillin and Caspase-3 in Breast Invasive Ductal Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(1): 22-25. doi: 10.3969/j.issn.1000-8179.2012.01.006

乳腺浸润性导管癌中Paxillin和Caspase-3蛋白的表达及临床意义

doi: 10.3969/j.issn.1000-8179.2012.01.006
详细信息
    通讯作者:

    李孟圈  lmq10332@126.com

Expression and Clinical Significance of Paxillin and Caspase-3 in Breast Invasive Ductal Carcinoma

More Information
  • 摘要:   目的  探讨桩蛋白(Paxillin)和天冬氨酸特异性半胱氨酸蛋白酶-3(Caspase-3)在乳腺浸润性导管癌(IDC)中的表达及其与乳腺浸润性导管癌(IDC)患者临床病理因素的关系。   方法  采用免疫组化检测术中切除的原发性乳腺浸润性导管癌(IDC)和距癌灶约5 cm处正常乳腺组织中Paxillin和Caspase-3的表达,统计学分析两者间及其与乳腺浸润性导管癌(IDC)病理特征的关系。   结果  Paxillin在IDC组的表达高于正常乳腺组织组,差异具有统计学意义(P < 0.05);Caspase-3在IDC组的表达低于正常乳腺组织组,差异具有统计学意义(P < 0.05)。在IDC组中,Paxillin的表达与Her-2状态相关,2种蛋白的表达与乳腺IDC的淋巴结转移及组织学分级相关,2种蛋白在IDC中的表达呈负相关(r=-0.32,P=0.013)。   结论  Paxillin和Caspase-3的的异常表达在乳腺浸润性导管癌(IDC)的发生、发展中可能起着重要的作用,且与乳腺浸润性导管癌(IDC)的浸润转移密切相关。

     

  • 图  1  Paxillin在乳腺组织中的表达(SP×200)

    A:乳腺癌组织;B:正常乳腺组织

    Figure  1.  Staining of paxillin(SP×200)

    图  2  Caspase-3在乳腺组织中的表达(SP×200)

    A:乳腺癌组织;B:正常乳腺组织

    Figure  2.  Staining of caspase-3(SP×200)

    表  1  Paxillin和Caspase-3蛋白表达与乳腺IDC临床病理参数的关系  例(%)

    Table  1.   The relationship of paxillin and caspase-3 expression with clinicopathologic parameters of breast IDC

    表  2  Paxillin和Caspase-3蛋白表达在乳腺IDC中的关系  例

    Table  2.   The relationship between the expression of paxillin and caspase-3 protein in breast IDC

  • [1] Sattler M, Pisick E, Morrison PT, et al. Role of the cytoskeletal protein paxillin in oncogenesis[J]. Crit Rev Oncol, 2000, 11(1): 63-76.
    [2] Yang XF, Xin Y, Mao LL. Clinicopathological significance of pten and caspase-3 expressions in breast cancer[J]. Chin Med Sci J, 2008, 23(2) : 95-102. doi: 10.1016/S1001-9294(09)60019-5
    [3] McGregor BA, Antoni MH. Psychological intervention and health outcomes among women treated for breast cancer: A review of stress pathways and biological mediators[J]. Brain Behav Immun, 2009, 23(2): 159-166. doi: 10.1016/j.bbi.2008.08.002
    [4] Deakin NO, Turner CE. Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis [J]. Mol Biol Cell, 2011, 22(3): 327-341. doi: 10.1091/mbc.e10-09-0790
    [5] Livasy CA, Moore D, Cance WG, et al. Focal adhesion kinase overexpression in endometrial neoplasia[J]. Appl Immunohistochem Mol Morphol 2004, 12(4): 342-345. doi: 10.1097/00129039-200412000-00009
    [6] 李海刚, 谢德荣, 黎洪浩, 等. 肝细胞癌Paxillin和VEGF的表达及其临床意义[J]. 中国肿瘤临床, 2004, 31(7): 412-413. http://www.cjco.cn/cn/article/doi/
    [7] 孙兴华, 王亚红, 马彬, 等. Paxillin和HER-2在乳腺癌中的表达及意义[J]. 辽宁医学院学报, 2009, 30(3): 203-206. doi: 10.3969/j.issn.1674-0424.2009.03.005
    [8] Sen A, O'Malley K, Wang Z, et al. Paxillin regulates androgenand epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells[J]. J Biol Chem, 2010, 285(37): 28787-28795. doi: 10.1074/jbc.M110.134064
    [9] Chen T, Wong YS, Zheng W, et al. Caspase and p53-dependent apoptosis in breast carcinoma cells induced by asynthetic selenadiazole derivative[J]. Chem Biol Interact, 2009, 180(1): 54-60. doi: 10.1016/j.cbi.2008.12.010
    [10] 应荣彪, 冯俊, 李建军, 等. 胃癌中survivin和caspase-3的表达及其临床意义[J]. 中国癌症杂志, 2010, 20(1): 17-21. doi: 10.3969/j.issn.1007-3639.2010.01.004
    [11] 王强, 杨志雄, 廖思海. Fas、FasL和Caspase-3在肺癌中的表达及其临床意义[J]. 现代肿瘤医学, 2009, 17(2): 248-251. doi: 10.3969/j.issn.1672-4992.2009.02.020
    [12] Deakin NO, Turner CE. Paxillin comes of age[J]. J Cell Sci, 2008, 121(Pt 15): 2435-2444. http://pubmedcentralcanada.ca/articlerender.cgi?accid=pmc2522309
    [13] Phipps LE, Hino S, Muschel RJ. Targeting cell spreading: a method of sensitizing metastatic tumor cells to TRAIL-induced apoptosis [J]. Mol Cancer Res, 2011, 9(3): 249-258. doi: 10.1158/1541-7786.MCR-11-0021
    [14] Short SM, Yoder BJ, Tarr SM, et al. The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study[J]. Breast J, 2007, 13(2): 130-139. doi: 10.1111/j.1524-4741.2007.00389.x
  • 加载中
图(2) / 表(2)
计量
  • 文章访问数:  30
  • HTML全文浏览量:  4
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-08-10
  • 修回日期:  2011-11-19

目录

    /

    返回文章
    返回